GoodRx Holdings (GDRX) stock Forecast for 2022 – 2026
Last update: 05-17-2022, 14:04
Sector: HealthcareThe share price of GoodRx Holdings, Inc. (GDRX) now
What analysts predict:: $12.96
52-week high/low: $48.05 / $7.33
50/200 Day Moving Average: $15.89 / $30.72
This figure corresponds to the average price over the previous 50/200 days. For GoodRx Holdings stocks, the 50-day moving average is the resistance level today.
For GoodRx Holdings stocks, the 200-day moving average is the resistance level today.
Are you interested in GoodRx Holdings, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the GoodRx Holdings stock price in 2022, 2023, 2024, 2025, 2026. How much will one GoodRx Holdings share be worth in 2022 - 2026?
When should I take profit in GoodRx Holdings stock? When should I record a loss on GoodRx Holdings stock? What are analysts' forecasts for GoodRx Holdings stock? What is the future of GoodRx Holdings stock?
We forecast GoodRx Holdings stock performance using neural networks based on historical data on GoodRx Holdings stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
GoodRx Holdings stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for GoodRx Holdings shares. This happens once a day.
Historical and forecast chart of GoodRx Holdings stock
The chart below shows the historical price of GoodRx Holdings stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GoodRx Holdings stock price can be found in the table below.
Long-term forecasts by years.
GoodRx Holdings daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 19 | 8.40 | 8.32 | 8.55 | 2.77 |
| May 20 | 8.30 | 8.16 | 8.36 | 2.48 |
| May 21 | 8.11 | 8.03 | 8.19 | 2.01 |
| May 22 | 8.19 | 8.07 | 8.29 | 2.73 |
| May 23 | 8.29 | 8.11 | 8.37 | 3.26 |
| May 24 | 8.43 | 8.24 | 8.58 | 4.07 |
| May 25 | 8.42 | 8.32 | 8.49 | 2.07 |
| May 26 | 8.53 | 8.35 | 8.69 | 4.06 |
| May 27 | 8.48 | 8.38 | 8.65 | 3.14 |
| May 28 | 8.41 | 8.25 | 8.56 | 3.71 |
| May 29 | 8.28 | 8.13 | 8.32 | 2.37 |
| May 30 | 8.45 | 8.39 | 8.61 | 2.62 |
| May 31 | 8.48 | 8.31 | 8.65 | 4.03 |
| Jun 01 | 8.51 | 8.44 | 8.60 | 1.95 |
| Jun 02 | 8.53 | 8.36 | 8.61 | 3.00 |
| Jun 03 | 8.67 | 8.59 | 8.73 | 1.67 |
| Jun 04 | 8.70 | 8.52 | 8.83 | 3.57 |
| Jun 05 | 8.61 | 8.50 | 8.78 | 3.26 |
| Jun 06 | 8.49 | 8.32 | 8.58 | 3.17 |
| Jun 07 | 8.43 | 8.36 | 8.51 | 1.75 |
| Jun 08 | 8.54 | 8.47 | 8.73 | 3.08 |
| Jun 09 | 8.34 | 8.28 | 8.38 | 1.27 |
| Jun 10 | 8.37 | 8.22 | 8.55 | 4.05 |
| Jun 11 | 8.51 | 8.34 | 8.57 | 2.71 |
| Jun 12 | 8.47 | 8.38 | 8.57 | 2.23 |
| Jun 13 | 8.49 | 8.43 | 8.67 | 2.76 |
| Jun 14 | 8.53 | 8.40 | 8.63 | 2.67 |
| Jun 15 | 8.49 | 8.30 | 8.66 | 4.35 |
| Jun 16 | 8.44 | 8.38 | 8.50 | 1.44 |
| Jun 17 | 8.49 | 8.34 | 8.63 | 3.45 |
GoodRx Holdings Daily Price Targets
GoodRx Holdings Stock Forecast 05-19-2022.
Pessimistic target level: 8.32
Optimistic target level: 8.55
GoodRx Holdings Stock Forecast 05-20-2022.
Pessimistic target level: 8.16
Optimistic target level: 8.36
GoodRx Holdings Stock Forecast 05-21-2022.
Pessimistic target level: 8.03
Optimistic target level: 8.19
GoodRx Holdings Stock Forecast 05-22-2022.
Pessimistic target level: 8.07
Optimistic target level: 8.29
GoodRx Holdings Stock Forecast 05-23-2022.
Pessimistic target level: 8.11
Optimistic target level: 8.37
GoodRx Holdings Stock Forecast 05-24-2022.
Pessimistic target level: 8.24
Optimistic target level: 8.58
GDRX (GDRX) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 8.49 | 7.97 | 8.92 | 10.62 |
| Jul. | 9.25 | 8.45 | 9.59 | 11.92 |
| Aug. | 9.07 | 8.52 | 9.75 | 12.62 |
| Sep. | 8.19 | 7.86 | 8.70 | 9.60 |
| Oct. | 8.60 | 8.02 | 9.10 | 11.80 |
| Nov. | 8.24 | 7.82 | 8.70 | 10.11 |
| Dec. | 7.88 | 7.33 | 8.49 | 13.71 |
GoodRx Holdings forecast for this year
GoodRx Holdings Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $8.49353. Pessimistic: $7.97. Optimistic: $8.92
GoodRx Holdings Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $9.24776. Pessimistic: $8.45. Optimistic: $9.59
GoodRx Holdings Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $9.0702. Pessimistic: $8.52. Optimistic: $9.75
GoodRx Holdings Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $8.18858. Pessimistic: $7.86. Optimistic: $8.70
GoodRx Holdings Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $8.60128. Pessimistic: $8.02. Optimistic: $9.10
GoodRx Holdings Stock Prediction for Nov 2022
An downtrend is forecast for this month with an optimal target price of $8.24003. Pessimistic: $7.82. Optimistic: $8.70
GoodRx Holdings Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $7.88406. Pessimistic: $7.33. Optimistic: $8.49
GoodRx Holdings (GDRX) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 8.28 | 7.58 | 8.66 | 12.51 |
| Feb | 8.70 | 8.02 | 9.34 | 14.09 |
| Mar | 9.48 | 9.19 | 10.26 | 10.43 |
| Apr | 8.49 | 8.10 | 8.70 | 6.80 |
| May | 8.27 | 7.92 | 8.63 | 8.27 |
| Jun | 7.77 | 7.45 | 8.51 | 12.50 |
| Jul | 7.65 | 7.47 | 8.27 | 9.66 |
| Aug | 7.44 | 6.99 | 7.76 | 9.89 |
| Sep | 7.14 | 6.92 | 7.31 | 5.27 |
| Oct | 6.86 | 6.57 | 7.35 | 10.53 |
| Nov | 7.01 | 6.51 | 7.25 | 10.32 |
| Dec | 7.83 | 7.13 | 8.07 | 11.64 |
GoodRx Holdings (GDRX) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 7.43 | 7.01 | 7.96 | 11.88 |
| Feb | 7.34 | 6.72 | 7.75 | 13.31 |
| Mar | 7.07 | 6.71 | 7.33 | 8.45 |
| Apr | 6.40 | 5.79 | 6.68 | 13.23 |
| May | 6.63 | 6.26 | 7.21 | 13.24 |
| Jun | 6.76 | 6.58 | 7.33 | 10.28 |
| Jul | 6.44 | 5.84 | 6.62 | 11.79 |
| Aug | 6.49 | 6.18 | 6.81 | 9.15 |
| Sep | 5.88 | 5.41 | 6.06 | 10.82 |
| Oct | 5.60 | 5.42 | 5.95 | 8.92 |
| Nov | 5.66 | 5.53 | 5.80 | 4.69 |
| Dec | 5.25 | 4.78 | 5.62 | 14.81 |
GoodRx Holdings (GDRX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.70 | 5.25 | 6.17 | 14.98 |
| Feb | 5.78 | 5.39 | 6.25 | 13.76 |
| Mar | 6.46 | 6.11 | 7.02 | 13.02 |
| Apr | 6.71 | 6.15 | 6.99 | 11.99 |
| May | 7.34 | 6.90 | 7.56 | 8.73 |
| Jun | 7.47 | 6.97 | 7.76 | 10.27 |
| Jul | 7.42 | 7.08 | 7.99 | 11.37 |
| Aug | 7.78 | 7.22 | 8.42 | 14.30 |
| Sep | 7.15 | 6.75 | 7.55 | 10.58 |
| Oct | 7.34 | 7.10 | 7.93 | 10.44 |
| Nov | 6.92 | 6.59 | 7.37 | 10.59 |
| Dec | 6.92 | 6.47 | 7.53 | 14.11 |
GoodRx Holdings (GDRX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 7.65 | 7.15 | 8.19 | 12.66 |
| Feb | 8.04 | 7.41 | 8.77 | 15.52 |
| Mar | 8.04 | 7.61 | 8.80 | 13.50 |
| Apr | 8.31 | 7.83 | 8.93 | 12.38 |
| May | 9.17 | 8.45 | 9.50 | 11.12 |
| Jun | 9.08 | 8.52 | 9.44 | 9.81 |
| Jul | 9.71 | 9.22 | 10.28 | 10.31 |
| Aug | 10.15 | 9.39 | 10.65 | 11.78 |
| Sep | 9.55 | 9.09 | 10.01 | 9.16 |
| Oct | 10.11 | 9.19 | 10.55 | 12.88 |
| Nov | 8.96 | 8.64 | 9.47 | 8.75 |
| Dec | 9.18 | 8.72 | 9.70 | 10.10 |
GoodRx Holdings information and performance
GoodRx Holdings IPO will take place on September 22, 2020. The company is a developer of a platform that collects various data from 70 thousand pharmacies and compares drug prices to find cheaper ones. The placement underwriters are Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays.
ABOUT IPO, SHAREHOLDERS AND PURCHASE OF GOODRX
Among the company’s shareholders are Silver Lake with a 35.3% stake (33.8% after the IPO), Francisco Partners with a 23.7% stake (22.1% after the IPO), Spectrum with a 15.4% stake (12 , 5% after the IPO) and Idea Men with a share of 17.9 %% (15.6% after the IPO). Silver Lake will IPO $ 100 million in Class A shares in a private placement that will take place concurrently with the IPO. In total, the company is placing 34.615 million shares, of which 23.4 million shares are sold by the company itself and 11.192 million – by the company’s shareholders. Throughout its history, the company has made two acquisitions – Iodine (a company that helps patients select the right drugs) in January 2017 and HeyDoctor (a telemedicine provider) in September 2019.
GoodRx Holdings Address
233 WILSHIRE BLVD., SUITE 990, SANTA MONICA, CA, US
Market Capitalization: 3 528 476 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 35 745 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -0.062
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: -0.071
Quarterly Revenue Growth YOY: 0.389
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 26.74
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 3.859
Enterprise Value (EV) /Revenue
EV To EBITDA: 38.6
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 82726000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A